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Abstract
There is recent interest in characterizing the subset of obese individuals who have healthy 
metabolic profiles yet only two studies have examined this group prospectively but not in racially 
diverse populations. We analyzed factors associated with the prevalence and incidence of 
metabolic syndrome (MetSyn) among individuals grouped by body mass index (BMI) categories 
in a multi-center, community-based cohort of 14,663 African-American and white men and 
women aged 45-64 years at recruitment in 1987-1989, the Atherosclerosis Risk in Communities 
study. Logistic and proportional hazards regression were utilized to estimate odds ratios (OR) for 
the prevalence and hazard ratios (HR) for incidence of MetSyn with 95% confidence intervals 
(CI). At visit 1, MetSyn was positively associated with age, female gender, African-American 
race, and inversely related to education, associations being more pronounced among normal 
weight (NW) subjects. Among those without MetSyn at visit 1, obese (OB) subjects were more 
likely to develop MetSyn compared with NW [HR (95% CI): 4.53 (4.09-5.01)]. Several factors 
were associated with incident MetSyn among NW, including older age [per year: 1.05 
(1.03-1.06)], female gender [vs. male: 1.29 (1.10-1.52)], heavy alcohol intake [vs. never: 0.75 
(0.59-0.94)] and physical activity [tertile 3 vs. tertile 1: 0.71 (0.58-0.86)] but not OB. Weight gain 
(>5%) was also more highly associated with MetSyn in NW [1.61 (1.28-2.02)] compared with OB 
[1.01 (0.85-1.20)]. We conclude that lifestyle factors may play a stronger role in development of 
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A subset of overweight and obese individuals have been documented to have normal 
metabolic profiles (1). These individuals, who include over 30% of obese [body mass index 
(BMI) >=30 kg/m2] and over 50% of overweight (BMI >=25 kg/m2 and <30 kg/m2) adults, 
have normal insulin sensitivity, blood pressure and lipid profiles (2). Some reports have 
suggested that despite an elevated body size, these “metabolically normal” individuals may 
have a risk of chronic disease similar to that of normal-weight individuals without metabolic 
abnormalities (3). Conversely, approximately 24% of normal-weight U.S. adults (BMI < 
25.0 kg/m2) are considered metabolically abnormal (2), placing them at elevated risk for 
chronic diseases that are typically associated with elevated BMI, when compared to 
metabolically healthy normal weight individuals. Understanding which individuals are at 
higher risk for metabolic syndrome, given their body size, could have implications for public 
health and clinical practice.
Few studies have evaluated correlates of the prevalence of metabolic subtypes within body 
size categories (2, 4, 5) and we know of only one reporting on sociodemographic and 
lifestyle factors (2). The most pressing, yet completely unaddressed question regarding the 
metabolic subtypes of obesity is their longitudinal patterns (6). To date, only two studies, 
both in Asian populations, have evaluated the stability of the metabolically healthy 
phenotype (7, 8). Therefore, we know little about the critical question of how common it is 
for metabolically healthy individuals to remain free from metabolic syndrome, or what 
factors are associated with the transition from the metabolically healthy condition to the 
metabolically unhealthy condition over time. There is concern that for some obese 
individuals, the metabolically healthy condition may represent a transition to the higher risk 
unhealthy phenotype, while others may maintain the more favorable metabolic profile 
indefinitely (6). Characterization of this pattern, including identification of lifestyle and 
sociodemographic factors will highlight significant areas relevant for public health and 
clinical interventions.
In the current study we evaluated factors associated with subgroups of body size defined by 
metabolic syndrome (MetSyn) at baseline in a cross-sectional analysis. Additionally, we 
examined the course of the metabolically healthy subgroups by examining incident MetSyn 
among these individuals, including identification of factors associated with this transition, 
and evaluated if these associations varied by body size.
Methods
Study Population
We used data from the Atherosclerosis Risk in Communities (ARIC) Study, a prospective 
cohort in four U.S. communities (Forsyth County, NC; Jackson, MS; suburban Minneapolis, 
MN; Washington County, MD) designed to study the etiology of atherosclerosis in a 
predominately biracial sample of adult men and women (9). The study was approved by the 
Institutional Review Boards at each site.
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The initial visit occurred between 1987 and 1989 and included 15,792 men and women aged 
45 to 64 years. Follow-up visits occurred approximately every 3 years (1990-1992, 
1993-1995 and 1996-1998) with participation rates of 93%, 86% and 81%, respectively. In-
home interviews by trained study personnel using standardized questionnaires were 
conducted at each visit and assessed sociodemographic and lifestyle factors relevant to 
cardiovascular disease and family medical history. Usual diet was assessed using a 66-item 
food frequency questionnaire modified from the instrument developed by Willett (10), while 
physical activity was assessed using a modified version of the Baecke questionnaire (11).
Blood pressure, anthropometric measures and fasting blood samples were collected in clinic 
visits conducted after the in-home interview. Three repeated blood pressure measurements 
were obtained using a random-zero sphygmomanometer and the second and third 
measurements were averaged. Body weight was measured using a calibrated scale with 
subjects in scrub suits without shoes and height was measured using a ruler. Waist 
circumference at the umbilicus was measured using a tape measure. Blood was collected 
from an antecubital vein into a vacuum tube with ethylenediamine tetraacetic acid (for 
lipids) or a serum separator gel (for glucose). Triglycerides, high density lipoprotein (HDL) 
and serum glucose were assayed using enzymatic methods, dextran-magnesium precipitation 
and hexokinase/glucose-6-phosphate dehydrogenase, respectively (9).
Outcome—The outcome for this study was the presence or incidence of MetSyn as defined 
by National Cholesterol Program's Adult Treatment Panel III (ATP III) guidelines (12) [3 or 
more of the following risk factors: (1) abdominal obesity, men: >40 in, women: >35 in; (2) 
elevated triglycerides: >=150 mg/dL; (3) low HDL cholesterol, men: <40 mg/dL, women: 
<50 mg/dL; (4) elevated blood pressure: >=130/>=85 mm Hg; (5) elevated fasting glucose: 
>=110 mg/dL] within body size subtype defined according to three standard BMI categories 
(normal weight: < 25 kg/m2, overweight: 25-29.9 kg/m2, obese: >= 30 kg/m2). The analysis 
of prevalent MetSyn at visit 1 included 14,663 subjects with adequate information to define 
or preclude a classification of MetSyn. Subjects were excluded from the analysis due to 
indeterminate MetSyn (n=202), missing BMI or BMI < 18.5 (n=164), missing total energy 
intake or total energy intake outside the ranges 500-3000 kcal/day for females, 800-4000 
kcal/day for males (13) (n=529), missing age, education, smoking, alcohol intake or physical 
activity (n=130). At visit 1 10,074 subjects did not meet the criteria for MetSyn, of which 
788 had indeterminate MetSyn status at visit 2; thus the analysis of incident MetSyn 
included the 9,286 subjects without a classification of MetSyn at visit 1. Subjects who were 
without MetSyn at visit 4, or who failed to participate in a specific visit were right censored.
Covariates—Covariates for both aims of this analysis included: age (continuous), sex 
(male, female), race (white, African-American), education level (less than high school, high 
school graduate or vocational school, attended college), smoking status (never, former, 
current), alcohol use (never/rare, former, light, medium, heavy), leisure time physical 
activity (tertiles of metabolic equivalent task-hours (Met-hours) per week) and total caloric 
intake (continuous). Weight change was calculated as the percent change between each visit 
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relative to the initial visit [(weight in kg in current visit – weight in kg at visit 1)/weight in 
kg at visit 1)].
Statistical Analysis
We used unconditional logistic regression analysis to estimate odds ratios (OR) and 95% 
confidence intervals (CI) for the association of sociodemographic and lifestyle variables 
with prevalent MetSyn at visit 1. Hazard ratios (HR) and 95% CI for the association of 
covariates with development of MetSyn were estimated using interval-censored proportional 
hazards regression. For analysis of development of MetSyn, body mass index and weight 
change were treated as time-varying covariates. To determine whether the relationship 
between covariates and MetSyn differed by BMI category, all models included interaction 
terms and BMI-specific effects were calculated through combination of relevant parameter 
estimates from these models. The likelihood ratio test with a significance level of 5% was 
used to determine heterogeneity of association across body size groups for each covariate 
with prevalence of MetSyn. Each model was adjusted for all other variables. Statistical 
analysis was conducted in Stata v. 11 (Stata Corp., College Station, TX).
Results
Prevalent Metabolic Syndrome at Visit 1
At visit 1, prevalence of MetSyn was most common among the obese (table 1). 
Nevertheless, a substantial proportion of obese individuals (39.8%) did not meet the ATP-III 
criteria for MetSyn.
Among all body size subgroups, MetSyn at visit 1 was more common among older 
individuals [table 2; OR (95% CI) per year increase, among normal weight: 1.08 
(1.06-1.10); overweight: 1.06 (1.05-1.07); obese: 1.03 (1.02-1.05); p-interaction: < 0.005], 
with greater association with decreasing body size. Women were more likely than men to 
have MetSyn if they were normal weight or overweight, yet were less likely if they were 
obese (p-interaction: < 0.005), with a similar pattern noted for African-Americans. A higher 
level of education was generally associated with lower prevalence of MetSyn, with the most 
pronounced effect among normal weight subjects [OR (95% CI): 0.48 (0.37-0.63)]. Those 
with MetSyn were more likely to be current smokers across all body size categories (p-
interaction: 0.20). Although inverse associations were noted between both moderate levels 
of drinking, and the highest level of physical activity and prevalent MetSyn among normal 
weight and overweight individuals, null associations were observed in the obese group; the 
heterogeneity of these effects did not reach statistical significance for either of these 
covariates.
Development of Metabolic Syndrome Among Those Healthy at Visit 1
The prevalence of MetSyn increased over the 4 follow-up visits among all body size 
subgroups, with the greatest increase seen among obese individuals (data not shown). 
Among the 9,286 participants without MetSyn at visit 1 and with sufficient follow-up, the 
incidence of MetSyn over 9 years was greatest among the obese [incidence rate (IR) per 
1000 person-years (95% CI): 70.3 (65.8-75.2)], with lower rates noted among overweight 
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[IR: 37.9 (36.0-39.8)] and normal weight individuals [IR: 15.4 (14.4-16.5)]. In adjusted 
models (table 3), the metabolically healthy obese (MHO) were much more likely to meet the 
criteria for MetSyn during the follow-up compared with metabolically healthy normal 
weight (MHN) individuals [hazard ratio (HR): 4.53 (4.09-5.01)] with a less-pronounced 
effect noted among the metabolically healthy overweight (MHOw) [HR: 2.73 (2.49-2.99)].
Over the 9 years of follow-up, a weight gain of 5% or greater from visit 1 was associated 
with an increased risk of developing MetSyn among MHN [table 3; HR: 1.61 (1.28-2.02)] 
and MHOw [HR: 1.24 (1.08-1.43)] but not among the MHO [HR: 1.01 (0.85-1.20); p-
interaction: 0.006]. Females were more likely to develop MetSyn, with the effect limited to 
the MHN and MHOw (p-interaction: <0.005). Higher education levels were inversely 
associated with development of MetSyn, and former and current smoking were positively 
associated with its development, with fairly uniform effects noted across body size 
subgroups (p-interaction, education: 0.20; smoking: 0.70). Light and moderate alcohol 
intakes were inversely associated with development of MetSyn overall, with the effect 
appearing somewhat stronger among MHN (p-interaction: 0.06). Similarly, an inverse 
association between incident MetSyn and physical activity was noted, and it appeared more 
prominent among those with smaller body size [MHN HR tertile 3 vs. tertile 1: 0.71 
(0.79-0.94), MHOw: 0.84 (0.75-0.95), MHO: 1.06 (0.90-1.25); p-interaction: 0.02].
Discussion
In this study of a racially diverse, community based cohort of men and women, we observed 
that while a substantial proportion of obese subjects were free of MetSyn at baseline (40%), 
they were over four times as likely to develop MetSyn over nine years of follow-up 
compared with normal weight adults. Body size emerged as the strongest single factor 
studied here, although weight gain, age and female gender were also positively associated 
with incident MetSyn. Greater physical activity was inversely associated; however, these 
associations were stronger among those with lower body size. Presence of MetSyn was more 
common among those of older age and among current smokers for all body size groups, 
while female gender and African-American race were positively associated with MetSyn 
among normal weight or overweight individuals only. Similarly, education, moderate 
drinking and physical activity were inversely associated with prevalent MetSyn in the non-
obese subgroups.
The clustering of cardiometabolic risk factors commonly referred to as the MetSyn has been 
noted since the 1920s and is hypothesized to be the consequence of an insulin resistant state 
(14). The association between MetSyn and chronic disease has been extensively studied, and 
the condition has been linked to cardiovascular disease, diabetes, and cancer (15, 16) which 
is believed to be due to its effects on dyslipidemia, insulin sensitivity and chronic systemic 
inflammation (17). The clinical criterion for identification of MetSyn has gone through a 
number of iterations, with several organizations separately or jointly releasing four formal 
definitions between 1998 and 2009 (18-23). According to a recent NHANES study, nearly a 
quarter of the U.S. men and women had MetSyn by the most recent 2009 ATP-III definition 
used here (24). These authors found that prevalence was highest in Mexican-Americans and 
lowest in African-Americans and was more common with increasing BMI and age, and 
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among current smokers, those with lower income, non-drinkers and those more physically 
inactive. We observed similar patterns regarding age, smoking and alcohol use, however the 
lower prevalence among African-Americans was limited to the obese while the inverse 
association with physical activity was only observed in normal weight and overweight 
subjects.
Although body size is strongly correlated with the clustering of cardiometabolic risk factors 
(24), a substantial number of overweight and obese individuals with normal metabolic 
profiles have been documented (1) as have normal weight individuals with abnormal 
metabolic profiles (2). This latter finding may be particularly noteworthy since 
metabolically unhealthy normal weight individuals may be more responsive to dietary and 
lifestyle interventions, which could significantly reduce their subsequent risk of serious 
cardiovascular and metabolic complications (25). While the presence of these subtypes has 
been documented, detailed data on sociodemographic and lifestyle factors associated with 
them is lacking. The singular study to examine these issues uses data from the 1999-2004 
National Health and Nutrition Examination Surveys (2). Wildman and colleagues report that 
among overweight and obese adults, the metabolically healthy phenotype was more 
common in younger adults, moderate alcohol drinkers, non-Hispanic blacks and those with 
higher levels of physical activity; associations also observed in the current analysis. 
Wildman et al. also found that normal-weight individuals were more likely to be 
metabolically abnormal if they were of older age and male gender, and less likely if they 
were moderately physically active; they further noted a non-significant positive association 
for current smokers. Our findings are in agreement with regard to age and smoking, yet we 
found that female gender correlated with prevalent MetSyn where they did not.
There has been a significant lack of study regarding the stability of the metabolically healthy 
obese condition, and particularly if the effects of factors associated with the transition from 
healthy to unhealthy obesity vary between obese and normal weight individuals.(6) Two 
recent analyses, both in Asian populations, have reported that metabolically healthy obese 
individuals have a much greater risk of developing metabolic syndrome when compared to 
healthy normal weight subjects.(7, 8) In the smaller of the two studies, which included 1,547 
Taiwanese men and women, increased rates of MetSyn were observed with greater BMI, 
with a greater than 24-fold rate of metabolic syndrome among those with BMI 27 or greater, 
compared to < 23.(8) Chang et al. reported that in a population of Korean men the rate of 
development of MetSyn was 68% greater among those with BMI>25 compared to those 
with BMI between 18.5 and 22.9; when limited to weight-stable subjects the rate of MetSyn 
in this BMI group increased to more than five-times the rate in the lower BMI category. 
Notably, both the Taiwanese and Korean studies included younger subjects than were in our 
cohort (18-59 years and 30-59 years, respectively) and both had less follow-up (average 5.4 
and 5.1 years, respectively). Our findings, which are the first to be reported in a racially 
diverse sample of men and women, are in agreement with these previous works that indicate 
that obesity is a significant factor in the development of MetSyn. Furthermore, within the 
obese subgroup we observed a moderate, yet statistically insignificant inverse association of 
incident MetSyn with weight loss. However, previous work has suggested that weight loss 
among obese women achieved through caloric restriction may decrease insulin sensitivity 
among the metabolically healthy, while improving insulin sensitivity among those with 
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impaired metabolism (26). This apparent discrepancy with our results may be due to 
differences in classification of metabolic health, however this could have implications for 
clinical and public health interventions aimed at weight reduction. Our findings of a positive 
association with age, and an inverse association with alcohol intake that appears stronger 
among normal weight and overweight individuals is unique and should be explored in more 
depth in future analyses. That smoking increased the risk of MetSyn across all body size 
groups is consistent with its hypothesized effect on blood pressure (27, 28), lipids and 
systemic inflammation. However, we did not note a difference in the effect of smoking 
across body size despite previous findings that may suggest otherwise (29). The inverse 
association between MetSyn and physical activity was similarly expected (30, 31), 
particularly since a previous analysis in this population reported a favorable relationship 
between physical activity and lipid levels, specifically HDL and triglycerides, among all 
individuals (32). Yet the lack of association among obese individuals was somewhat 
surprising given the known beneficial effects of increased activity. However, it has recently 
been suggested that the amount of exercise needed to improve metabolic health may vary by 
specific risk factor (33). Therefore, since obese individuals, even those who fail to meet the 
classification of MetSyn, typically possess more of these factors than normal weight or 
overweight individuals, then the association with activity may be more evident in the latter 
two groups. Further investigations to identify individual characteristics associated with the 
transition from metabolically healthy to unhealthy obesity could identify which 
interventions would provide the greatest impact for this high-risk subgroup.
Our analysis benefitted from repeated assessments of anthropometric and biologic 
measurements from a racially diverse community-based population of middle-aged men and 
women. A notable limitation of our study lies in the lack of a consistent definition for 
metabolic health. Here we utilized the currently accepted definition of MetSyn (23), 
however other studies examining metabolic subtypes of obesity have utilized alternative 
criteria, some of which include direct measures of insulin resistance (4, 34, 35), while others 
used schemes similar to the ATP-III definition (36-39), which vary considerably from study-
to-study. Despite its limitations, we elected to focus our analysis on the ATPIII definition 
since it is straightforward in its application, relevant for both normal weight and overweight 
individuals, and is an established clinical standard. Finally, although the majority of the 
covariates examined here were objective measures, the use of questionnaires to assess 
physical activity and total energy intake have known disadvantages including recall bias and 
measurement error. However, the Baecke physical activity questionnaire used in this study 
has been reported to be accurate and reliable in this population (40), and food frequency 
questionnaires are useful for examining correlations based on ranking of individuals relative 
intake, as was performed in this analysis (13).
In conclusion, we found that metabolically healthy obesity may not be a stable condition, as 
body size was a significant factor associated with development of the cluster of 
cardiometabolic abnormalities among those considered here. Among the normal weight 
individual, lifestyle factors, specifically weight maintenance, physical activity and moderate 
alcohol intake, appear to offer more protection against the development of this condition 
compared to those individuals of greater body size. These findings suggest that specific 
subsets of normal weight individuals may be more likely to develop this cluster of 
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cardiometabolic abnormalities and they may benefit from lifestyle interventions, while obese 
subjects may benefit most from interventions related to attainment of a healthy body size. 
Additional efforts are needed to clarify the definition of metabolic health, particularly within 
apparently high-risk groups, which will improve our ability to identify factors to prevent or 
reverse the clustering of these conditions among all body size groups.
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